Spread of tick-borne encephalitis virus in the Netherlands Every year about 1.5 million ticks bite someone in the Netherlands, especially between March and October. Most people will not get sick of that.
Sewage research: decline of novel coronavirus in the Netherlands The first results of RIVM’s National Wastewater Surveillance show that the novel coronavirus in sewage is decreasing in the Netherlands.
Results from the GGD test lanes for employees in education and childcare As of 1 June, anyone in the Netherlands with (mild) symptoms can be tested for COVID-19 in the GGD test lanes. People can sign up for a test, or be tested due to source and contact tracing.
Results from the GGD test lanes As of 1 June, anyone in the Netherlands with (mild) symptoms can be tested for COVID-19 in the GGD test lanes.
Many people willing to isolate at home in case of positive COVID-19 test The sense of threatening danger from the novel coronavirus is declining. People are feeling less anxious and despondent than in the initial phase of the coronavirus pandemic.
Corona crisis has limited impact on infant participation in National Immunisation Programme Nearly all infants in the Netherlands are still participating in the National Immunisation Programme.
Initial results on how COVID-19 spreads within Dutch families The novel coronavirus is primarily spread amongst adults who are about the same age. Within families, the virus is mainly transmitted from adults to children.
Less air pollution from traffic and industry but increased contribution from agriculture International air policy has shown good results in Europe: in the past 35 years the air has become cleaner. Nevertheless air pollution is still an important cause of premature death.
Early detection of work-related health risks in Europe At European level, different methods are used to identify substances and processes that may cause cancer as early as possible, the so-called early warning systems.
Burden of disease and societal costs of work-related cancer in the European Union Yearly approximately 122,600 people in the EU are diagnosed with cancer, caused by past exposure to carcinogenic substances at work.